OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

JAK-STAT pathway inhibitors in dermatology
Hélio Amante Miot, Paulo Ricardo Criado, Caio César Silva de Castro, et al.
Anais Brasileiros de Dermatologia (2023) Vol. 98, Iss. 5, pp. 656-677
Open Access | Times Cited: 45

Showing 1-25 of 45 citing articles:

Comparative efficacy of oral Janus kinase inhibitors and biologics in adult alopecia areata: A systematic review and Bayesian network meta‐analysis
Husein Husein‐ElAhmed, Sara Husein‐ElAhmed
Journal of the European Academy of Dermatology and Venereology (2024) Vol. 38, Iss. 5, pp. 835-843
Closed Access | Times Cited: 13

Emerging Oral Therapies for the Treatment of Psoriasis: A Review of Pipeline Agents
Anastasia Drakos, Tiago Torres, Ronald Vender
Pharmaceutics (2024) Vol. 16, Iss. 1, pp. 111-111
Open Access | Times Cited: 11

Inhibition of the JAK-STAT Pathway in the Treatment of Psoriasis: A Review of the Literature
Andreea Roxana Furtunescu, Simona Roxana Georgescu, Mircea Tampa, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 9, pp. 4681-4681
Open Access | Times Cited: 10

JAK Inhibitors in Cutaneous T-Cell Lymphoma: Friend or Foe? A Systematic Review of the Published Literature
Seyed Mohammad Vahabi, Saeed Bahramian, Farzad Esmaeili, et al.
Cancers (2024) Vol. 16, Iss. 5, pp. 861-861
Open Access | Times Cited: 9

Emerging Role of Janus Kinase Inhibitors in Treating Granuloma Annulare: A Clinical, Narrative Review of Efficacy and Safety
Sama Heidari, Reza Omid, Hanie Babaie, et al.
International Journal of Dermatology (2025)
Closed Access | Times Cited: 1

SOCS-JAK-STAT inhibitors and SOCS mimetics as treatment options for autoimmune uveitis, psoriasis, lupus, and autoimmune encephalitis
Rahul Pandey, Marina Bakay, Hákon Hákonarson
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 17

Pathogenesis of Inflammation in Skin Disease: From Molecular Mechanisms to Pathology
Simona N. Shirley, Abigail E. Watson, Nabiha Yusuf
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 18, pp. 10152-10152
Open Access | Times Cited: 6

Exploring the Therapeutic Effects of Anisole on Psoriasis in Mice Based on the JAK1/STAT3 Pathway
Qing Ning, Yingxue Yue, Xinlian Liu, et al.
Phytotherapy Research (2025)
Closed Access

The evolving therapeutic landscape in atopic dermatitis
Luis Angel Hernández-Zárate, Carlos Andrés Gómez-Núñez, Stefan Narváez-Labuhn, et al.
(2025) Vol. 3
Closed Access

Síndrome DRESS: uma interação entre medicamentos, vírus latentes e sistema imune
Paulo Ricardo Criado, Mayra Ianhez, Hélio Amante Miot, et al.
(2025) Vol. 100, Iss. 1, pp. 104-120
Open Access

Role of skin-homing t-cells in recurrent episodes of atopic dermatitis: a review
Huimin Guo, Huimin Yuan, Yanru Yu, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access

Exploring the shared genetic mechanisms of atopic dermatitis and alopecia areata via bioinformatics approaches
Qianqian Chen, Ting Yang, Jiayi Cheng, et al.
Archives of Dermatological Research (2025) Vol. 317, Iss. 1
Closed Access

Progress of mesenchymal stem cells affecting extracellular matrix metabolism in the treatment of female stress urinary incontinence
Chunyun Fang, Zhili Zeng, Junsong Ye, et al.
Stem Cell Research & Therapy (2025) Vol. 16, Iss. 1
Open Access

Pulsatilla koreana Nakai Extract Attenuates Atopic Dermatitis-like Symptoms by Regulating Skin Barrier Factors and Inhibiting the JAK/STAT Pathway
Hye Jin Kim, Musun Park, Seol Jang, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 7, pp. 2994-2994
Open Access

Aquaporin 3 inhibition attenuates imiquimod-induced psoriatic symptoms in a murine model
Ryosuke Okubo, Manami Tanaka, Akiharu Kubo, et al.
Molecular Biology Reports (2025) Vol. 52, Iss. 1
Open Access

Off‐Label Use of Topical Ruxolitinib in Dermatology: A Systematic Literature Review and Current Perspectives
Marco Spadafora, Serena Morsia, Vito Di Lernia, et al.
Experimental Dermatology (2025) Vol. 34, Iss. 4
Open Access

Serum Lipids Alterations in Patients Under Systemic JAK Inhibitors Treatments in Dermatology: Clinical Aspects and Management
Giovanni Paolino, Mario Valenti, Andrea Carugno, et al.
Medicina (2025) Vol. 61, Iss. 1, pp. 54-54
Open Access

Chronic pruritus: a narrative review
Paulo Ricardo Criado, Roberta Fachini Jardim Criado, Mayra Ianhez, et al.
Anais Brasileiros de Dermatologia (2025)
Open Access

New Perspectives in the Management of Chronic Hand Eczema: Lessons from Pathogenesis
Vittorio Tancredi, Dario Buononato, Stefano Caccavale, et al.
International Journal of Molecular Sciences (2023) Vol. 25, Iss. 1, pp. 362-362
Open Access | Times Cited: 7

Selective JAK 1 inhibition with upadacitinib as a potential treatment for coexistent severe atopic dermatitis and alopecia areata
Guilherme Muzy
Anais Brasileiros de Dermatologia (2024) Vol. 99, Iss. 3, pp. 483-484
Open Access | Times Cited: 2

Prurigo: review of its pathogenesis, diagnosis, and treatment
Paulo Ricardo Criado, Mayra Ianhez, Roberta Fachini Jardim Criado, et al.
Anais Brasileiros de Dermatologia (2024) Vol. 99, Iss. 5, pp. 706-720
Open Access | Times Cited: 2

Analysis of Reddit Reveals JAK Inhibitor Questions Among Atopic Dermatitis Patients
Kripa Ahuja, Grace DeSena, Peter Lio
Journal of Drugs in Dermatology (2024) Vol. 23, Iss. 4, pp. e121-e123
Open Access | Times Cited: 2

Page 1 - Next Page

Scroll to top